(Q33333334)

English

Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Bolwell B

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Vredenburgh J

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Overmoyer B

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Gilbert C

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Chap L

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Menchaca DM

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Cruickshank S

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Glaspy J

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

141-145

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

cMpl ligand is a humoral regulator of megakaryocytopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Purification and characterization of thrombopoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

21 January 2018

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702465

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702465

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33333334&oldid=2195253251"